Financial Consulate’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$46.8K Buy
314
+47
+18% +$6.59K 0.01% 351
2026
Q2
$33.7K Sell
267
-11
-4% -$1.45K ﹤0.01% 413
2026
Q1
$38.7K Buy
278
+42
+18% +$5.88K ﹤0.01% 369
2025
Q4
$28.9K Buy
236
+109
+86% +$13.2K ﹤0.01% 406
2025
Q3
$14.1K Buy
+127
New +$14.4K ﹤0.01% 509

Other funds holding GILD

Financial Consulate's GILD Position: Q3 2026 in Review

Financial Consulate increased its Gilead Sciences (GILD) stake by 18% in Q3 2026, buying an estimated $6.59K and bringing the position to 314 shares worth $46.8K. The position accounts for 0.01% of the portfolio, ranked #351.

Financial Consulate first reported a position in GILD in Q3 2025 and has held it in 5 quarters since. 664 funds tracked by Wall St. Rank hold GILD as of Q3 2026.

  • Financial Consulate held 314 shares of Gilead Sciences worth $46.8K as of Q3 2026.
  • Financial Consulate bought 47 Gilead Sciences shares in Q3 2026, an estimated $6.59K.
  • Gilead Sciences made up 0.01% of Financial Consulate's portfolio in Q3 2026, its #351 holding.
  • Financial Consulate first reported a position in Gilead Sciences in Q3 2025 and has held it in 5 quarters since.
  • 664 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2026.

Based on Financial Consulate's 13F filing for Q3 2026, filed 23 Oct 2026.